Session #1: April 20, 2026 @ 3:00 p.m. CST
Gerard Slobogean, MD, MPH (UC Irvine) will discuss the state of the science regarding the platform trial approach, which is capable of simultaneously evaluating multiple interventions. Sheila Sprague, PhD, MSc (McMaster University) will follow with information about the Musculoskeletal Adaptive Platform Trial (MAPT), a platform trial protocol that investigators can license to conduct their own interventional trials. Learn about this innovative trial design and find out how you can license the MAPT master protocol free of charge or engage the investigator support to provide oversight and trial management.

Question Title

1. First Name (Required.)

Question Title

2. Last Name (Required.)

Question Title

3. Credentials

Question Title

4. Primary Institution or Organization (Required.)

Question Title

5. Email Address (Required.)

Thanks for registering! We'll send you a calendar invite within 48 hours. If registering close to air time, here's the Zoom link:
https://us02web.zoom.us/j/83095834607?pwd=OVcx0vcqbYlquqBvtpLxF7bHRWEfUY.1&from=addon

T